Bank of America’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Bank of America’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-6,300	Closed	-$71K	–	7505
2017 Q3	$71K	Hold	6,300	–	–	﹤0.01%	5804
2017 Q2	$69K	Buy	+6,300	New	+$63K	﹤0.01%	5751

Bank of America's SCLN Position: Q4 2017 in Review

Bank of America sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 65,031 shares — an estimated $729K sold.

Bank of America first reported a position in SCLN in Q2 2013 and held it in 18 quarters. The position peaked at $861K in Q2 2014. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Bank of America reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Bank of America sold 65,031 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $729K.
Bank of America first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 18 quarters.
Bank of America's Sciclone Pharmaceuticals Inc position peaked at $861K in Q2 2014.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Bank of America's 13F filing for Q4 2017, filed 14 Feb 2018.